Lokivetmab Injectable Solution

276 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

276

Total Reports

Deaths Reported

690.0%

Death Rate

Active Ingredients

Lokivetmab Injectable Solution

Administration Routes

UnknownParenteralSubcutaneousOtherIntramuscular

Species Affected

Dog 275

Cat 1

Most Affected Breeds

Retriever - Labrador 34

Crossbred Canine/dog 17

Shih Tzu 15

Shepherd Dog - German 13

Bulldog - French 13

Terrier - Yorkshire 13

Retriever - Golden 10

Pit Bull 9

Pug 8

Shepherd Dog - Australian 8

Most Reported Reactions

Vomiting 46

Lack of efficacy - NOS 43

Lethargy (see also Central nervous system depression in Neurological) 32

Diarrhoea 25

Elevated serum alkaline phosphatase (ALP) 22

Elevated alanine aminotransferase (ALT) 15

Anorexia 14

Other abnormal test result NOS 14

Not eating 13

Death by euthanasia 13

Decreased appetite 13

Panting 13

Outcome Breakdown

Ongoing

112 (40.6%)

Outcome Unknown

100 (36.2%)

Recovered/Normal

44 (15.9%)

Euthanized

13 (4.7%)

Died

6 (2.2%)

Recovered with Sequela

1 (0.4%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.